Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients

Cancer Research

Volumn 61, Issue 3, 2001, Pages 1122-1128

  Simmons, Martha L ^a   Lamborn, Kathleen R ^a   Takahashi, Michelle ^a   Chen, Pengchin ^a   Israel, Mark A ^a   Berger, Mitchel S ^a   Godfrey, Tony ^a   Nigro, Janice ^a   Prados, Michael ^a   Chang, Susan ^a   Barker, Fred G ^b   Aldape, Ken ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; PROTEIN P53;

ADULT; AGE; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE ASSOCIATION; GENE OVEREXPRESSION; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; AGED; BRAIN NEOPLASMS; CELL DIVISION; FEMALE; GENES, P53; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035111058     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme
2. Correlates of survival and the Daumas-Duport grading system for astrocytomas
3. Alterations of the TP53 gene in human gliomas
4. Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost
5. Prognostic scoring in adult astrocytic tumors using patient age, histopathological grade, and DNA histogram type
6. Primary and secondary glioblastomas: From concept to clinical diagnosis
7. Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours
8. MDM2 and p53 expression in gliomas: A multivariate survival analysis including proliferation markers and epidermal growth factor receptor
9. p53 immunohistochemical positivity as a prognostic marker in intracranial tumours
10. Prognostic factors in malignant glioma: Influence of the overexpression of oncogene and tumor-suppressor gene products on survival
11. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes
12. Analysis of proliferation markers and p53 expression in gliomas of astrocytic origin: Relationships and prognostic value
13. Prognostic implications of p53 overexpression in supratentorial astrocytic tumors
14. p53 status has no prognostic significance in glioblastomas treated with radiotherapy
15. Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations
16. Lack of prognostic relevance of alterations in the epidermal growth factor receptor-transforming growth factor-a pathway in human astrocytic gliomas
17. Epidermal growth factor receptor: An independent predictor of survival in astrocytic tumors given definitive irradiation
18. Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcome
19. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: Demonstration of the variability of the intermitotic cycle time
20. MIB-I proliferation index predicts survival among patients with grade II astrocytoma
21. Prognostic significance of Ki-67 proliferation index in supratentorial fibrillary astrocytic neoplasms
22. Relationships between Ki-67 labelling index, amplification of the epidermal growth factor receptor gene, and prognosis in human glioblastomas
23. Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas
24. Statistical modelling in analysis of prognosis in glioblastoma multiforme: A study of clinical variables and Ki-67 index
25. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas
26. The new WHO classification of brain tumours
27. Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas
28. Validation of fluorescent SSCP analysis for sensitive detection of p53 mutations
29. Constitutional p53 mutations associated with brain tumors in young adults
30. Histopathologic and immunohistochemical prognostic factors in malignant gliomas
31. Extent of resection as a prognostic variable in the treatment of gliomas
32. Regional treatment of epidermal growth factor receptor viii-expressing neoplastic meningitis with a single-chain immunotoxin, MR-1
33. Inhibitory effect of antisense epidermal growth factor receptor RNA on the proliferation of rat C6 glioma cells in vitro and in vivo